Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Endothelium-derived vascular relaxing factor.

M J Peach, A L Loeb, H A Singer

    Hypertension (Dallas, Tex. : 1979)
    |May 1, 1985
    PubMed
    Summary
    This summary is machine-generated.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    [Heller myotomy by transthoracic procedure, a single center experience in Mali with 21 cases].

    Le Mali medical·2018
    Same author

    Ca<sup>2+</sup>/Calmodulin-Dependent Protein Kinase II in Vascular Smooth Muscle.

    Advances in pharmacology (San Diego, Calif.)·2017
    Same author

    [Necrotizing cervico-facial cellulitis of dental origin in a developing country].

    Revue des maladies respiratoires·2016
    Same author

    New insight into the effects of heparinoids on complement inhibition by C1-inhibitor.

    Clinical and experimental immunology·2016
    Same author

    Anxiety in patients having caesarean section under regional anaesthesia: a questionnaire and pilot study.

    International journal of obstetric anesthesia·2004
    Same author

    DPC 681 and DPC 684: potent, selective inhibitors of human immunodeficiency virus protease active against clinically relevant mutant variants.

    Antimicrobial agents and chemotherapy·2001

    Vasoactive compounds relax arterial smooth muscle by triggering endothelial cells to release endothelium-derived relaxing factor (EDRF). This labile factor activates guanylate cyclase, leading to smooth muscle relaxation and unknown roles in cardiovascular homeostasis.

    Area of Science:

    • Cardiovascular Physiology
    • Endothelial Function
    • Pharmacology

    Background:

    • Numerous compounds induce indirect arterial smooth muscle relaxation.
    • Endothelial receptors bind vasodilators, initiating relaxation signaling.
    • Endothelium-derived relaxing factor (EDRF) is proposed for this relaxation mechanism.

    Purpose of the Study:

    • To investigate the nature and mechanism of endothelium-derived relaxing factor (EDRF).
    • To characterize the signaling pathway of EDRF in vascular smooth muscle.
    • To explore the role of EDRF in cardiovascular homeostasis.

    Main Methods:

    • Pharmacological studies using various vasodilators and inhibitors.
    • Experiments involving EDRF transfer and reversal of relaxation.

    Related Experiment Videos

  • Assays measuring guanylate cyclase activity and cyclic GMP levels.

    • Main Results:

    • EDRF is a labile substance released from endothelial cells.
    • EDRF activates smooth muscle guanylate cyclase, increasing cyclic GMP.
    • Pharmacological evidence regarding EDRF's origin (e.g., arachidonic acid) remains equivocal.

    Conclusions:

    • EDRF is a key mediator of endothelium-dependent vasodilation.
    • The precise identity and full physiological role of EDRF are yet to be determined.
    • EDRF's activation of guanylate cyclase is a significant finding for further research.